HITOX 200U Clinical Specification

Purified neurotoxin complex (900kDa) derived from Clostridium botulinum Hall strain. Kquality-assured clinical equivalence. biomanufacturing facility.

FOR MEDICAL PROFESSIONALS ONLY

Onset: 72-120 hours post-administration

Peak Efficacy: 14 days

Duration: 16-24 weeks (dose-dependent)

Diffusion: 0.6-1.2cm² target radius

Active Toxin: 200 Units Botulinum Toxin Type A (900kDa)

Excipient 1: 0.5mg Pharmaceutical-Grade Human Serum Albumin (HSA)

Excipient 2: 0.9mg Sodium Chloride (Isotonic Buffer)

Immunogenicity: ≤0.1% resistance risk in Phase III trials

Vacuum-Drying Stabilization

Proprietary lyophilization methodology ensures residual moisture remains <0.1%. Prevents protein denaturation during transit. Shelf-life validated at 36 months under controlled 2-8°C (36-46°F) refrigeration.